United States · FDA National Drug Code directory
Labetalol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 29300-254_8325a41d-d05c-4c6b-b2fc-260c9380bfba
- Product NDC
- 29300-254
- Form
- TABLET, FILM COATED
- Composition / generic term
- Labetalol Hydrochloride
- Labeler
- Unichem Pharmaceuticals (USA), Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221001
- Source listing expiry
- 20271231
Source-listed ingredients
- LABETALOL HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (29300-254-01) · 29300-254-01
- 500 TABLET, FILM COATED in 1 BOTTLE (29300-254-05) · 29300-254-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →